Neurocrine Biosciences NBIX Business Segments — Investment income and other, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept nbix:InvestmentIncomeAndOtherNet.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's business segments — investment income and other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's business segments — investment income and other, net?
- Neurocrine Biosciences (NBIX) reported business segments — investment income and other, net of $28.1M in Q1 2026.
- How has Neurocrine Biosciences's business segments — investment income and other, net changed year-over-year?
- Neurocrine Biosciences's business segments — investment income and other, net increased by 29.5% year-over-year, from $21.7M to $28.1M.
- What is the long-term trend for Neurocrine Biosciences's business segments — investment income and other, net?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's business segments — investment income and other, net has grown at a 180.3% compound annual growth rate (CAGR), from $4.1M to $90.3M.
- What does business segments — investment income and other, net mean?
- Includes interest earned on cash and cash equivalents, as well as other non-operating income or expenses. This provides a view of the company's treasury management and non-core financial activities.